| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.41 | 0.0003 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |